$0.930.93 -0.07-0.07 |(-6.98-6.98 %)
52W H: 1.6952W L: 0.4589Beta: 0.39
About Brainstorm Cell Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://brainstorm-cell.com/
Frequently Asked Questions
What is the 52-week range for BCLI?
The 52-week high is $1.69 and the 52-week low is $0.4589.
What is the P/E ratio for BCLI?
The P/E ratio data is currently unavailable.
What is the dividend yield for BCLI?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -236.36%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 7.50.
Analyst Recommendation Trends
Wall Street analyst consensus for BCLI over the last few months:
2026-09-01
Buy: 0
S.Buy: 0
Hold: 3
Sell: 1
2026-08-01
Buy: 0
S.Buy: 0
Hold: 3
Sell: 1
2026-07-01
Buy: 0
S.Buy: 0
Hold: 3
Sell: 1
2026-06-01
Buy: 0
S.Buy: 0
Hold: 3
Sell: 1
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-07-24 | FRENKEL JACOB A | +100,000 | - | - |
| 2026-07-24 | Pitts Peter Joe | +900,000 | - | - |
| 2026-02-26 | Lebovits Chaim | +1,800,000 | - | - |
| 2026-02-26 | Yablonka Uri | +150,000 | - | - |
| 2026-02-26 | Patlis Alla | +100,000 | - | - |
| 2026-02-26 | FRENKEL JACOB A | +200,000 | - | - |
| 2026-02-26 | ARBEL IRIT | +120,000 | - | - |
| 2026-02-26 | Bairu Menghisteab | +150,000 | $0.7 | $105,000 |
| 2026-02-26 | Polverino Anthony J. | +150,000 | $0.7 | $105,000 |
| 2026-02-26 | HARTOUNIAN HARTOUN | +225,000 | $0.7 | $157,500 |
| 2026-02-26 | Lindborg Stacy | +150,000 | $0.7 | $105,000 |
| 2026-02-26 | Naor Nir | +180,000 | $0.7 | $126,000 |
| 2026-02-26 | Dagher Ibrahim B. | +225,000 | $0.7 | $157,500 |